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Background: Atriplex laciniata L. was investigated for phenolic, flavonoid contents, antioxidant, anticholinesterase
activities, in an attempt to explore its effectiveness in Alzheimer’s and other neurological disorders. Plant crude
methanolic extract (Al.MeF), subsequent fractions; n-hexane (Al.HxF), chloroform (Al.CfF), ethyl acetate (Al.EaF),
aqueous (Al.WtF), Saponins (Al.SPF) and Flavonoids (Al.FLVF) were investigated for DPPH, ABTS and H2O2 free radical
scavenging activities. Further these extracts were subjected to acetylcholinesterase (AChE) & butyrylcholinesterase
(BChE) inhibitory activities using Ellman’s assay. Phenolic and Flavonoid contents were determined and expressed in
mg Gallic acid GAE/g and Rutin RTE/g of samples respectively.
Results: In DPPH free radicals scavenging assay, Al.FLVF, Al.SPF and Al.MeF showed highest activity causing 89.41 ±
0.55, 83.37 ± 0.34 and 83.37 ± 0.34% inhibition of free radicals respectively at 1 mg/mL concentration. IC50 for these
fractions were 33, 83 and 82 μg/mL respectively. Similarly, plant extracts showed high ABTS scavenging potential,
i.e. Al.FLVF (90.34 ± 0.55), Al.CfF (83.42 ± 0.57), Al.MeF (81.49 ± 0.60) with IC50 of 30, 190 and 70 μg/ml respectively.
further, H2O2 percent scavenging was highly appraised in Al.FLVF (91.29 ± 0.53, IC50 75), Al.SPF (85.35 ± 0.61, IC50 70)
and Al.EaF (83.48 ± 0.67, IC50 270 μg/mL). All fractions exhibited concentration dependent AChE inhibitory activity as;
Al.FLVF, 88.31 ± 0.57 (IC50 70 μg/mL), Al.SPF, 84.36 ± 0.64 (IC50 90 μg/mL), Al.MeF, 78.65 ± 0.70 (IC50 280 μg/mL), Al.EaF,
77.45 ± 0.46 (IC50 270 μg/mL) and Al.WtF 72.44 ± 0.58 (IC50 263 μg/mL) at 1 mg/mL. Likewise the percent BChE
inhibitory activity was most obvious in Al.FLVF 85.46 ± 0.62 (IC50 100 μg/mL), Al.CfF 83.49 ± 0.46 (IC50 160 μg/mL),
Al.MeF 82.68 ± 0.60 (IC50 220 μg/mL) and Al.SPF 80.37 ± 0.54 (IC50 120 μg/mL).
Conclusions: These results stipulate that A. laciniata is enriched with phenolic and flavonoid contents that possess
significant antioxidant and anticholinestrase effects. This provide pharmacological basis for the presence of compounds
that may be effective in Alzheimer’s and other neurological disorders.
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Free radical especially reactive oxygen species (ROS), such
as superoxide (O2
−), hydroxyl (OH) and hydrogen peroxide
(H2O2) have greater brunt on human both from within
the body and from their surroundings. If the body fails to
eliminate, ROS can attack on biomolecules such as lipids,
proteins, enzymes, DNA and RNA. Though, human body
possesses many defense mechanisms through antioxidant
enzymes and non-enzymatic compounds against these
oxidative stresses. But when these free radicals go out of
control, the organism becomes incapable to scavenge all
ROS which may lead to the development of chronic dis-
eases, such as cancer, arteriosclerosis, nephritis, diabetes
mellitus, liver injury, rheumatism, ischemia, cardiovascu-
lar and neurodegenerative disorders such as Alzheimer’s
and Parkinson’s disease [1]. Chemical agents, radiation,
toxins, deep fried foods and environmental factors such as
pollution, radiation, cigarette smoke and herbicides can
generate these reactive free radicals [2].
Among the neurological disorders, Alzheimer’s disease
(AD) is one of indefinite neurodegenerative diseases and is
the most common cause of dementia [3]. AD is character-
ized by deposition of amyloid plaque having insoluble pro-
tein fragments, Amyloid Beta (Aβ), and by manifestation of
neurofibrillary tangles in the region of hippocampus and
cortex [4]. AD is also associated with loss of synapses, syn-
aptic dysfunctions, mitochondrial abnormalities and inflam-
matory stress [5] that may lead to multi neurotransmitters
deficiency like, acetylcholine [6], noradrenalin [7], serotonin
[8] and somatostatin [9]. Acetylcholine (neurotransmitter)
is involved in the signal transmission in the synapse and its
pharmacological action is terminated primarily by AChE
and secondly by BChE [10]. Therefore, inhibitors of these
metabolizing enzymes have become important alternatives
in the treatment of AD [11]. Federal Drug Administration
(FDA) have approved Tacrine, Rivastigmine, Donepezil, for
symptomatic treatment, but these drugs do not impede the
progression of disease and are associated with various ad-
verse effects [12]. Besides these, anti inflammatory drugs
[13], antioxidants [14], calcium channel blockers [15], chol-
esterol lowering drugs and metal chelating agents [16] pos-
sess a protective role in AD. Medicinal plants used in the
form of crude drugs, spices and vegetables have been widely
used in Chinese and Ayurvedic cultures for many centuries
to restore declining cognitive functions [17]. Several plants
are have been identified for its role in dementia such as
Curcuma longa, Zingiber officinale [18], Huperzia serrata
(toothed clubmoss) [19], Ginkgo Biloba [20], Catharanthus
Roseus [21], Panax ginseng [22], and Galanthus nivalis;
which contains Galanthamine, an anticholinestrase alkaloid
has been recently approved for the treatment of AD [23].
Scientists have shown interest to treat and prevent AD with
herbs, spices and vegetables [24]. The medicinal plants can
produce the therapeutic effect by producing antiamyloideffect, antioxidant effect, antiapoptotic effect, enhancing
synaptic functions, inhibiting cholinesterase and N-Methyl
D-Aspartate (NMDA) receptors [25]. Herbal drugs have
dominance over synthetic drug because they show less tox-
icity, easily cross blood brain barrier and exert multiple syn-
ergistic effects [24]. Medicinal plants used traditionally have
been improved cholinergic and cognitive functions by acting
as cholinesterase inhibitors in-vitro as well as in-vivo [23,26].
Thus evaluating these enzymes inhibitory and antioxidants
effects of natural products in vitro may be used as treatment
option in AD and other cognitive dysfunctions [24].
Similarly phenols and flavonoids are important plant
secondary metabolites, that’s having conjugated ring
structures and hydroxyl groups, that may have the po-
tential to function as antioxidants by scavenging the free
radicals which are involved in oxidative processes via hy-
drogenation or complexation with oxidizing species and
may resist many oxidative stresses and diseases [2]. The
incessant formation of free radicals in human’s body can
be controlled naturally and synthetically by different
valuable compounds known as antioxidants. Presently
butylated hydroxy toluene (BHT), butylated hydroxy ani-
sole (BHA), gallic acid esters and tertiary butylated
hydroquinon available synthetic antioxidants, but their
use is restricted and there is a propensity to surrogate
them with natural antioxidants that may be found in
medicinal plants [27]. Several reports on the antioxidant
and radical-scavenging activities of crude extracts and
pure natural compounds have been reported [28,29].
A. laciniata (Chenopodiaceae), a halophyte, one of the
salt bushes species of Atriplex. Commonly known by their
English name cut-leaf saltbush, Belgian orach, four wings
saltbush, frosted orache, frosted sea orach. The plant is
native to Australia, North America, South America and
Eurasia [30]. Ethno botanists have not indicated any trad-
itional use of this plant in Pakistan. Though, no toxico-
logical or pharmacological studies have been carried out in
detail so far on this specie. However antimicrobial, antineo-
plastic, analgesic, antipyretic, anthelmintic, insecticidals,
cytotoxic, antioxidants, anticholinesterase, gastro and hep-
atotoxic, antiparasites, laxative, sedative activities have
already been reported in various species of Chenopodiaceae
[31,32]. Research has been paying attention on the bio-
logical effects of plants which are traditionally used as cho-
linesterase inhibitors and radical scavenging in-vitro as well
as in-vivo [33]. This study is also focused on preliminary
anticholinestrase and antioxidant potential of A. laciniata.
Results
Total phenolic and flavonoid content
The extraction yield of phenolics (mg GAE/g of sample)
and flavonoids (mg RTE/ g of sample) contents in differ-
ent fractions of A. laciniata are presented in Table 1. Al.
MeF, Al.EaF and Al.CfF fractions exhibited high phenolic
Table 1 Total phenolics and flavonoids contents of crude methanolic and their subsequent fractions of
Atriplex laciniata
Samples Total phenolics (mg GAE/g of sample) Total flavonoids (mg RTE/g of sample)
Al.MeF 311.32 ± 0.54 144.37 ± 0.52
Al.HxF 152.59 ± 0.48 14.38 ± 0.51
Al.CfF 231.12 ± 0.58 160.41 ± 0.55
Al.EaF 278.79 ± 0.45 52.33 ± 0.46
Al.WtF 190.62 ± 0.62 82.25 ± 0.55
GAE = galic acid equivalent, RTE = rutin equivalent, each value in the table is represented as mean ± SEM (n = 3).
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152.59 ± 0.48 (Al.HxF), 231.12 ± 0.58 (Al.CfF), 278.79 ±
0.45 (Al.EaF) and 190.62 ± 0.62 (Al.WtF) mg GAE/g of
sample. Whereas, total flavonoids (mg RTE/g of sample)
were 144.37 ± 0.52 (Al.MeF), 14.38 ± 0.51 (Al.HxF),
160.41 ± 0.55 (Al.CfF), 52.33 ± 0.46 (Al.EaF) & 82.25 ±
0.55 (Al.WtF).The concentration of phenolics among
different fractions were in an ascending order of Al.MeF
> Al.EaF > Al.CfF > Al.WtF > Al.HxF. Similarly Al.CfF
and Al.MeF fractions exhibited highest flavonoid con-
tents. The ascending order for total flavonoids contents
were Al.CfF > Al.MeF > Al.Wtf > Al.EaF > Al.HxF.
DPPH radical scavenging effect
Comparatively the most stable organic radical DPPH is
extensively used in modeling systems to explore the
scavenging activities of several natural compounds, such
as phenolics, flavonoids, as well as crude mixtures, such
as methanolic, n-hexane, ethyl acetate or water extracts
from plants. The antioxidants scavenged the DPPH rad-
ical through the donation of electrons forming the re-
duced DPPH, upon which color changes from purple to
yellow. Table 2 shows concentration dependent DPPH
percent inhibitions and IC50 values for radical scaven-
ging activities of crude saponins, flavonoids and different
extract fractions of the A. laciniata. Among the tested
fractions In DPPH radical scavenging evaluation Al.FLVF
(IC50 33 μg/mL), Al.SPF (IC50 83 μg/mL) and Al.MeF
(IC50 82 μg/mL) shows highest percent inhibitions in
concentration dependent manner that may be attributed
due to their high phenolic and flavonoid contents. The
DPPH free radical scavenging potential of the tested
fractions were in an ascending order Al.FLVF > Al.SPF >
Al.MeF > Al.CfF > Al.EaF > Al.Wtf > Al.HxF. In Al.FLVF
the difference in P (>0.O5) value were statistically non
significant in comparison with positive control at highest
concentrations.
ABTS free radical scavenging assay
Crude extracts of A. laciniata exhibited high activity
against ABTS free radicals at various concentrations that
was comparable with DPPH scavenging, as summarized
in Table 2. Among different fractions, Al.FLVF was mostpotent (IC50 30 μg/mL), followed by Al.CfF, Al.MeF and
Al.SPF with IC50 of 190, 70 and 92 μg/mL respectively.
The ABTS percent inhibitions were compared with the
positive control ascorbic acid (IC50 37 μg/mL).
Hydrogen peroxide scavenging activity
Results of H2O2 percent scavenging are summarized in
Figure 1, IC50 values are given in Figure 2. Al.FLVF (91.29 ±
0.53) displayed greater H2O2 percent scavenging than the
standard ascorbic acid (87.76 ± 0.60) at highest concentra-
tion. Similarly Al.SPF (85.35 ± 0.61) and Al.EaF (83.48 ±
0.67) shows comparable results, that reflects the presence of
antioxidant potential in A. laciniata.
Correlation between antioxidant, total phenolic
and flavonoid contents
The correlation coefficients (R2) of antioxidant activity
(DPPH, ABTS and H2O2), total phenolic contents
(TPC) and total flavonoid contents (TFC) of Al.MeF, Al.
HxF, Al.CfF, Al.EaF and Al.WtF are shown in Figure 3.
The R2 values of %DPPH inhibition versus TPC
(Figure 3A) and TFC (Figure 3B) are 0.66 and 0.65,
wherein % ABTS inhibition versus TPC (Figure 3C) and
TFC (Figure 3D), that is 0.52 and 0.69 respectively, that
indicate a moderate correlation between DPPH, ABTS,
TPC and TFC of A. laciniata extracts. Likewise, R2 in %
H2O2 inhibition versus TPC (Figure 3E) and TFC (Fig-
ure 3F) are 0.62 and 0.20 respectively. From this statis-
tics, we determined a poor correlation between % H2O2
inhibition and TFC while moderate correlation versus
TPC. Linear regression analysis showed a moderate cor-
relation between antioxidant activity versus total phen-
olic and flavonoid contents. High phenolic and
flavonoid content is only one of the antioxidant capacity
indicators.
Acetylcholinesterase (AChE) and butyrylcholinesterase
(BChE) inhibition
Inhibition of AChE and BChE are the key enzymes in
the breakdown of acetylcholine and butyrylcholine that
may be considered as one of the treatment approaches
against several neurological disorders such as Alzheimer’s
disease, senile dementia, ataxia, and myasthenia gravis.
Table 2 Results of antioxidant potential of Atriplex laciniata against DPPH and ABTS free Radicals using ascorbic acid
as standard
Samples Conc. (μg/mL) DPPH Percent inhibition DPPH IC50 (μg/mL) ABTS Percent inhibition ABTS IC50 (μg/mL)
Al.MeF 1000 83.23 ± 0.44** 82 81.49 ± 0.60*** 70
500 79.50 ± 0.61 ns 75.45 ± 0.59**
250 68.47 ± 0.46*** 64.52 ± 0.60***
125 53.47 ± 0.70*** 57.58 ± 0.57***
Al.HxF 1000 65.57 ± 0.43*** 270 69.90 ± 1.04 *** 215
500 58.12 ± 0.94*** 61.53 ± 0.65***
250 48.76 ± 1.09*** 52.20 ± 1.04***
125 34.38 ± 0.50*** 40.50 ± 0.73***
Al.CfF 1000 74.50 ± 0.56*** 210 83.42 ± 0.57*** 190
500 61.40 ± 0.55*** 72.32 ± 0.52***
250 52.36 ± 0.57*** 58.27 ± 0.57***
125 43.30 ± 0.52*** 37.30 ± 0.64***
Al.EaF 1000 69.37 ± 0.58*** 382 76.34 ± 0.63*** 360
500 62.29 ± 0.43*** 67.54 ± 0.46***
250 24.58 ± 0.56*** 33.48 ± 0.60***
125 17.39 ± 0.60*** 28.52 ± 0.66***
Al.WtF 1000 67.83 ± 1.07*** 210 69.37 ± 1.10*** 310
500 61.56 ± 0.69*** 57.56 ± 0.45***
250 52.48 ± 0.54*** 46.36 ± 0.55***
125 40.90 ± 1.16*** 35.57 ± 0.84***
Al.SPF 1000 83.37 ± 0.52** 83 78.40 ± 0.51*** 92
500 73.38 ± 0.76*** 71.44 ± 0.55***
250 67.24 ± 0.80*** 63.47 ± 0.52***
125 54.40 ± 0.76*** 52.39 ± 0.49***
Al.FLVF 1000 89.41 ± 0.55 ns 33 90.34 ± 0.55 ns 30
500 83.27 ± 0.58 ns 86.36 ± 0.49***
250 76.35 ± 0.51 ns 73.52 ± 0.62 ns
125 63.28 ± 0.57 * 67.42 ± 0.55 ns
Ascorbic Acid 1000 87.90 ± 0.96 14 89.30 ± 0.61 37
500 83.08 ± 0.47 80.37 ± 0.54
250 79.85 ± 2.24 73.37 ± 0.64
125 67.36 ± 0.57 64.45 ± 0.65
Values significantly different as compared to positive control, *:P < 0.05, **:P < 0.01, ***:P < 0.001, ns: P >0.05. Values expressed as Percent inhibition
(Mean ± SEM of n = 3) and IC50.
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a cognitive function and to alleviate other symptoms as-
sociated with Alzheimer’s disease nowadays [1]. Table 3
shows the AChE and BChE percent inhibitions and IC50
values of the A. laciniata various crude extracts using
Galantamine as a positive control. Generally, the ex-
tracts exhibited a dose-dependent AChE and BChE per-
cent inhibitions. At highest concentrations, all the crude
fractions had a better AChE and BChE percent inhib-
ition values ranging from 64.36 ± 0.61 to 88.31 ± 0.57.
Al.FLVF, Al.SPF and Al.MeF showed most potent AChEIC50 values of 70, 90, 280 μg/mL respectively as com-
pared to that of Galantamine 52 μg/mL. The ascending
order for AChE inhibitory activity among the tested
fractions were Al.FLVF > Al.SPF > Al.MeF > Al.EaF > Al.
HxF > Al.Wtf > Al.CfF. Similarly Al.FLVF, Al.CfF and Al.
MeF displaying the most effective BChE median inhibi-
tory concentrations (IC50) of 100, 160 and 220 μg/mL
respectively, while that for the positive control was
47 μg/mL. The BChE inhibitory activity among the given
fractions were in rising order of Al.FLVF > Al.CfF > Al.
MeF > Al.SPF > Al.Wtf > Al.EaF > Al.HxF.























































Figure 1 Antioxidant assay of plant extracts using H202 assay. Values represent percent radical scavenging (mean ± SEM) of three replicates.
Values significantly different as compare to positive control *:P < 0.05, **:P < 0.01 and ***:P < 0.001.
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Natural products showing their therapeutic potential and
effectiveness in the treatment and management of neuro-
degenerative diseases such as Alzheimer’s, Parkinson and
Epilepsy are getting much consideration in this modern
era. There has been a continuous search for the develop-
ment of novel and cost effective drugs from natural
sources. The therapeutic and pharmacological properties
of A. laciniata have not been reported in any journal be-
fore. The results of the present study suggest that this
plant may be a generous source of secondary metabolites,
which act as natural antioxidants and cholinesterase
inhibitors.
A. laciniata extracts contained high levels of total phen-
olic and flavonoid contents. The extraction yield of TPC
and TFC were reported in Table 1. Previous reports indi-
cate that phenols and flavonoids are free radical termina-
tors and scavengers that may be attributed due to their













Figure 2 IC50 values For antioxidant activity of Plant extracts
using H2O2 assay.of OH group’s substitution [34,35]. In the current study,
the correlation coefficient for phenolic, flavonoid contents
in Al.MeF, Al.HxF, Al.CfF, Al.EaF, Al.WtF versus activities
including DPPH, ABTS free radical scavenging indicates
that phenols and flavonoids were the main components re-
sponsible for the antioxidant behavior of crude extracts.
Similarly Al.FLVF and Al.SPF also exhibited strapping anti-
oxidant via DPPH reduced to DPPH-H, prevention of
ABTS to ABTS++ radical cationation and break down of
peroxides. It has been found that plant metabolites such as
vitamins, like E and C, carotenoids or enzymes involved in
the antioxidant mechanisms, shows their biochemical ef-
fects via several mechanisms, including hindrance of chain
initiation, chelation of metal ions, breakdown of peroxides,
sustained hydrogen abstraction, reductive ability and radical
scavenging [36]. The free radicals like hydroxyl, nitric oxide,
superoxide & lipid peroxyl and non-free radicals mostly in-
clude singlet oxygen and hydrogen peroxide, can be scav-
enged by natural antioxidants, that may be beneficial in
various physiological and neurodegenerative disorders [37].
Though in all living organism there is a protective antioxi-
dant system that protect the body systems from the conse-
quences of free radical formations [36].
The acetylcholinesterase enzyme is an attractive target
for the rational drug design and for the discovery of
mechanism based inhibitors because of its role in the
hydrolysis of the neurotransmitter acetylcholine. AChE
inhibitors are the most effective approach to treat the
cognitive symptoms of Alzheimer disease and other
possible therapeutic applications in the treatment of
Parkinson.s disease, senile dementia, and ataxia, among
others. Additionally the extract showed considerable anti-
cholinesterase inhibition, approximately halving the break-
down of substrate by human cholinesterase. All the plant
extracts contained some level of inhibitory activity against




Figure 3 Correlation coefficients (R2) of antioxidant activity, for total phenolic vs DPPH (A), total phenolic vs ABTS (C), total phenolic vs
H2O2 (E) and flavonoid contents Vs DPPH (B), flavonoid contents Vs ABTS (D) and flavonoid contents Vs H2O2 (F) in crude various fractions
of Atriplex laciniata L.
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tions had the lowest IC50 value, indicating that they con-
tained the best inhibition of the enzyme. A significant
correlation of antioxidant activity versus total phenolic
contents and anticholinesterase potential versus total phen-
olic contents demonstrates that the phenolic compounds
present in this plant specie are responsible for these activ-
ities which necessitate the further exploration of this plant
for the isolation of bioactive compounds. Previous reports
also demonstrates the presence of anticholinesterase com-
pounds in various plant samples, which goes parallel with
our current study [36,38-41].
Conclusion
Based on the significant antioxidant and anticholines-
terase potentials of A. laciniata it may be inferred that
A. laciniata is a good source of anti-Alzheimer and
neuro-protective natural compounds especially the
polyphenolic compounds. Evidenced from the results, it
may also be concluded that further isolation and
characterization of this plant may lead to novel drug
candidates against Alzheimer’s and neuro-degenerative
disorders.Methods
Plant collection, extractions and fractionation
The whole plant of A. laciniata was collected in May 2012
from ring road, Peshawar, Khyber Pukhtunkhwa (KPK),
Pakistan. The plant was identified by botanical taxonomist
Dr. Ali Hazrat Department of Botany, Shaheed Benazir
Bhutto University, Sheringal Dir Upper, KPK, Pakistan
and plant sample was deposited at the herbarium of the
same University with voucher no. 1014.ZK.SBBU. The
whole plant was subjected to shade drying. The dried
plant was then grinded to fine powder. The powdered ma-
terials (6 Kg) were soaked in commercial grade methanol
85% (24 liters) for 15 days, as 1 Kg crude drug will be dis-
solved in 4 liter of methanol [42]. The crude extracts were
filtered through filter paper and this process was repeated
three times. The filtrates were concentrated at 40°C under
reduced pressure, using a rotary evaporator (Heidolph,
Germany), till a brownish crude extract (425 g) was
obtained. The brownish Al.MeF (425 g, 7.08% of the
whole powder) was dissolved in 1600 mL distilled water
and was successively fractionated with (500 mL of each
solvent, three times each) n-hexane, chloroform, and ethyl
acetate [43]. The Al.MeF was fractionated by solvent–
Table 3 AChE & BChE inhibitiory potentials of plant extracts using galanthamine as standard
Samples Concentrations (μg/mL) Percent Inhibition (AChE) AChE IC50 (μg/mL) Percent inhibition (BChE) BChE IC50 (μg/mL)
Al.MeF 1000 78.65 ± 0.70*** 280 82.68 ± 0.60*** 220
500 67.25 ± 0.55*** 69.42 ± 0.60***
250 47.21 ± 0.62*** 52.51 ± 0.66***
125 31.55 ± 0.56*** 41.27 ± 0.62***
Al.HxF 1000 72.51 ± 0.62*** 64.36 ± 0.61*** 400
500 63.44 ± 0.44*** 310 53.40 ± 0.52***
250 42.46 ± 0.47*** 39.46 ± 0.60***
125 23.68 ± 0.64*** 22.52 ± 0.49***
Al.CfF 1000 67.42 ± 0.46 *** 83.49 ± 0.46*** 160
500 53.53 ± 0.41*** 390 72.48 ± 0.50***
250 40.62 ± 0.69*** 59.59 ± 0.66***
125 18.46 ± 0.67*** 45.57 ± 0.63***
Al.EaF 1000 77.45 ± 0.55 *** 74.41 ± 0.60*** 260
500 57.63 ± 0.64*** 270 61.53 ± 0.71***
250 48.45 ± 0.66 *** 49.45 ± 0.77***
125 36.36 ± 0.50*** 31.75 ± 0.58***
Al.WtF 1000 72.44 ± 0.58*** 78.62 ± 0.36*** 210
500 60.51 ± 0.59*** 263 69.22 ± 0.47***
250 48.62 ± 0.70*** 52.52 ± 0.71***
125 31.47 ± 0.55*** 43.52 ± 0.70***
Al.SPF 1000 84.36 ± 0.64 *** 80.37 ± 0.54*** 120
500 77.34 ± 0.65*** 90 73.44 ± 0.50***
250 65.58 ± 0.67*** 62.51 ± 0.72***
125 53.60 ± 0.50*** 49.28 ± 0.61***
Al.FLVF 1000 88.31 ± 0.57ns 85.46 ± 0.62*** 100
500 79.46 ± 0.63 * 70 76.58 ± 0.69***
250 67.53 ± 0.49 *** 65.68 ± 0.42***
125 59.38 ± 0.50ns 52.46 ± 0.72***
Galanthamine 1000 91.37 ± 0.65 94.50 ± 0.71 47
500 83.33 ± 0.55 52 85.47 ± 0.59
250 73.31 ± 0.60 71.72 ± 0.51
125 61.32 ± 0.54 65.37 ± 0.69
Result expressed as % inhibition (mean ± SEM of n = 3) and IC50 values. Values significantly different as compared to positive control, *:P < 0.05, ***:P < 0.001,
ns: P >0.05.
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gm, 1.65%), Al.CfF (26.0 gm, 6.1%), and Al.HxF (12.0 gm,
2.9%) and the residual Al.WtF (80.0 gm, 18.9%) fractions.
Extraction of crude saponins
For the extraction of saponins, 20 g of powdered of plant
sample were put into a conical flask; then 100 mL of
20% ethanol was added. The sample was then put into a
water bath having temperature of 55°C for 4 hours with
continuous stirring. The mixture obtained was filtered
and the residue was extracted again with 200 mL ethanol
(20%). The volume obtained was put into a water bathand the volume which was approximately 300 mL was
concentrated to 40 mL which was then transferred into
a separating funnel, adding 20 mL of diethyl ether into it
with vigorous shaking. The separating funnel was kept
for a while in a stand to obtain two layers; aqueous and
organic. The aqueous layer obtained was recovered while
the organic layer obtained was discarded and the process
was repeated so that to achieve purification. After that
60 mL of n-butanol were added into the aqueous layer
and put for a while. Then 10 mL of 5% NaCl solution
was added to wash the combined n-butanol extract. The
solution remained was evaporated by keeping in a hot
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dried form [44]. Near about 5.93 gm (29.65%) of Al.SPF
were obtained.
Extraction of crude flavonoids
For flavonoids extraction, standard procedure was followed.
Briefly, 20 g powder of plant sample was extracted twice
with 200 mL of 80% aqueous methanol at room
temperature. The whole solution was then filtered through
Whatman filter paper No-1. The filtrate was later trans-
ferred into crucibles. The sample was then put into a
waterbath to evaporate until dryness. The dry residue left
is the crude flavonoids [45]. This is then weighted to a
constant weight (1.57 gm, 7.85% of the total weight).
Chemicals and drugs
DPPH (CAS 1898-66-4 Sigma Aldrich CHEMIE GmbH
USA), ABTS (CAS 30931-67-0 Sigma Aldrich USA),
K2S2O4 (Riedel-de Haen Germany), Gallic acid and Folin
Ciocalteu reagent (FCR) were purchased from Merck Co.
(Germany). Enzymes including acetylcholinesterase Electric
eel (type-VI-S, CAS 9000-81-1 Sigma-Aldrich GmbH USA
), butyrylcholinesterase equine serum Lyophilized (CAS
9001-08-5 Sigma-Aldrich GmbH USA), substrates acet-
ylthiocholine iodide (CAS1866-15-5 Sigma-Aldrich UK),
butyrylthiocholine Iodide CAS 2494-56-6 Sigma-Aldrich
Switzerland), DTNB 5,5-dithio-bis-nitrobenzoic acid (CAS
69-78-3 Sigma-Aldrich Germany), Galanthamine hydrobro-
mide Lycoris Sp. (CAS 1953-04-4 Sigma-Aldrich France)
were used for enzyme inhibition study. For preparation of
buffer, di-potassium hydrogen phosphate (K2HPO4), Potas-
sium di-hydrogen phosphate (KH2PO4), potassium hydrox-
ide used were of extra pure analytical grade, Hydrogen
peroxide (H2O2).
Total phenolic content
The hydroxyl groups on the phenols in the plant constitu-
ents give them radical scavenging ability which may be
directly correlated with the antioxidant activity [46]. So
for the determination of total phenolic contents in plant
extract of A. laciniata, the procedure used by Kim et al.,
[47] was followed. In this method, 1 mL of diluted extracts
was added to 9 mL of distilled water, followed by addition
of Folin-Ciocalteu’s reagent (1 mL) was added to it and
properly shake. After 5 minutes 10 mL of 7% Na2CO3 so-
lution was transferred into it and properly mixed. The
mixture was diluted with 25 mL distilled water and mixed
well. After 90 minutes the absorbance was measured at
750 nm using spectrophotometer (Thermo electron cor-
poration, USA). Gallic acid standard curve was used as a
reference to measure the total phenolic contents. The
total phenolic contents were expressed as mg of Gallic
Acid equivalent.Total flavonoid content
It has also been reported that the antioxidant activity of
plant extract is attributed to the total flavonoid contents
[48]. While for total flavonoid contents the procedure
followed by Park et al., [49] were pursued. In this 0.3
mL of the plant extracts, 0.15 mL of 0.5 M NaNO2, 3.4
mL of 30% methanol and 0.15 mL of 0.3 M AlCl3.6H2O
were added to 10 mL test tube and was properly mixed.
After 5 minutes, 1 mL of 1 M NaOH was added. Ab-
sorbance of mixture was measured at 506 nm. Rutin
standard solution (0 to 100 mg/L) was used for deter-
mination of total flavonoids content and were expressed
as mg of Rutin equivalent [50].DPPH radical scavenging activity
DPPH radical scavenging potential of plant samples were
determined using procedure adopted by Brand-Williams
et al., [51]. For preparation of DPPH solution, 24 mg of
DPPH was dissolved in 100 mL of methanol. Stock solu-
tions (1 mg/mL) of plant extracts were prepared in
methanol and were diluted to the concentrations of 125,
250, 500 and 1000 μg/mL. From these solutions, 1 mL
was mixed with 1 mL of DPPH solution and was incu-
bated at 23°C for 30 minutes. Absorbance was measured
at 517 nm using UV Spectrophotometer (Thermo elec-
tron corporation, USA). Ascorbic acid was used for posi-
tive control, percent scavenging activity was calculated
as; [(ABlank – ASample)/ABlank] × 100, where ABlank repre-
sent absorbance of control and ASample is the absorbance
of the plant extracts. Each experiment was done in tripli-
cate and inhibition curves were constructed using the
GraphPad prism program (GraphPad prism, San Diego,
California, USA) and median inhibitory concentrations
(IC50) values were determined.ABTS free radical scavenging assay
The antioxidant potential of A. laciniata, was also evalu-
ated using 2, 2-azinobis [3-ethylbenzthiazoline]-6-sulfonic
acid (ABTS) [52]. The assay is based on the capacity of an-
tioxidants to scavenge ABTS+ radical cation causing a re-
duction in absorbance at 734 nm. In brief ABTS 7 mM
and potassium persulphate (K2S2O4) 2.45 mM solutions
were prepared and mixed. The resultant mixture was
stored in dark at room temperature for 12–16 h to get
dark colored solution containing ABTS radical cations.
Prior to use, ABTS radical cation solution was diluted
with Phosphate buffer (0.01 M) pH 7.4, to adjust an ab-
sorbance value of 0.70 at 734 nm. Radical scavenging abil-
ity of the fractions was analyzed by mixing 300 μl of test
sample with 3.0 mL of ABTS solution in cuvette. The re-
duction in absorbance was measured spectrophotometric-
ally, one minute after mixing the solutions and continued
for six min. Ascorbic acid was used as positive control.
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Percent scavenging effect ¼ control absorbance−sample absorbance
control absorbance
 100:
The antioxidant effect was expressed in terms of per-
cent inhibition and as EC50 (Extract concentration re-
quired for 50% reduction of ABTS radicals.
Hydrogen peroxide scavenging activity
For the detection of hydrogen peroxide scavenging activity
in the plant sample of A. laciniata, procedures of the
Ruch et al., [53] were followed. First prepared 2 mM solu-
tion of hydrogen peroxide in 50 mM phosphate buffer
(pH = 7.4). Then 0.1 mL of various plant samples were
taken in test tube and their volume were made 0.4 mL by
addition of 50 mM phosphate buffer. Add 0.6 mL of
hydrogen peroxide to it. After 10 minutes measure the ab-
sorbance of each sample at 230 nm against the blank [54].
Use the following equation for the calculation of hydrogen
peroxide scavenging activity;





Acetylcholinesterase (AChE) from Electric eel and butyr-
ylcholinesterase (BChE) from equine serum were used to
explore the enzymes inhibitory potential of A. laciniata,
its subsequent fractions, Al.FLVF and Al.SPF using Ell-
man’s assay [55]. The assay is based on the hydrolysis of
acetylthiocholine iodide or butyrylthiocholine iodide by
the respective enzymes and the formation of 5-thio-2-
nitrobenzoate anion followed by complexation with
DTNB to give yellow color compound which is detected
with a spectrophotometer beside the reaction time.
Preparation of solutions
Crude extract, subsequent fractions, Al.SPF and Al.FLVF
were dissolved in phosphate buffer (0.1 M) in concentra-
tions ranging from 125–1000 μg/mL. For the prepar-
ation of 0.1 M and 8.0 ± 0.1 PH phosphate buffer
solution, K2HPO4 (17.4 g/L) and KH2PO4 (13.6 g/L)
were prepared and were mixed in 94% and 6% ratio re-
spectively. Finally potassium hydroxide was used to ad-
just PH. Then AChE (518 U/mg solid) and BChE (7–16
U/mg) were diluted in freshly prepared buffer pH 8.0
until a final concentration of 0.03 U/mL and 0.01 U/mL
were obtained. Solutions of DTNB (0.0002273 M), ATchI
and BTchI (0.0005 M) were prepared in distilled water
and were kept in Eppendorf caps in the refrigerator.
Galanthamine (Positive control) was dissolved in metha-
nol and afore mentioned dilutions were prepared.Spectroscopic analysis
For each assay, an enzyme solution of 5 μl was added to
the cuvette, followed by addition of plant extract solution
(205 μl), and finally DTNB reagent (5 μl). The solution
mixture was maintained at 30°C for 15 min using water
bath, and subsequently the substrate solution (5 μl) was
added. A double beam spectrophotometer was used to
measure the absorbance at 412 nm. Negative control con-
tained all components apart from the plant extracts,
whereas positive control galanthamine (10 μg/mL) was
used in the assay as standard cholinesterase inhibitor. The
absorbance along with the reaction time were taken for
four minutes at 30°C and were repeated in triplicate. Fi-
nally the enzyme activity and enzyme inhibition by control
and tested samples were calculated from the rate of ab-
sorption with change in time (V =ΔAbs /Δt) as follow;
V ¼ ΔAbs=Δt
% enzyme activity ¼ V=Vmax 100
% enzyme inhibition ¼ 100‐% enzyme activity
Estimation of IC50 values
Concentrations of the plant extract at which 50% of in-
hibition is observed (IC50) were calculated among the in-
hibition percentages against the extract concentrations
via the Excel program.
Statistical data analysis
All the assays were repeated in triplicate and vales were
expressed as means ± Standard error means (SEM). Stat-
istical analyses were performed by Two-Way analysis of
variance (ANOVA), followed by Bonferroni post-tests.
The difference was considered to be statistically signifi-
cant when the p value was less than 0.05.
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